Pro APP Prosthetic Outcome Registry for Lower-Limb Amputation
This study, called the Pro APP Prosthetic Outcome Registry, is collecting information from people who use lower-limb prostheses (artificial limbs). It's not testing a new drug or treatment, but rather observing how people use their prostheses, what types of devices they have, and their long-term health outcomes. The goal is to gather data over 10 years to understand patient characteristics. You might be able to join if you are 18 or older, have lost a lower limb, and can understand study instructions. The study is currently unclear on its recruitment status, but aims to enroll 2000 participants.
- Study design
- This is an observational study, meaning it collects information without giving new treatments. It aims to enroll 2000 participants.
- What's involved
- You would participate in data collection as part of your standard clinic visits. This data would be entered by your healthcare providers.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be evaluated during follow-up visits as part of their standard care, with data collected for up to 10 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Pro APP Prosthetic Outcome Registry
At a glance
Conditions
NCT06210620
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Össur Americas
Irvine, Californiastudy coordinator listed
Recruiting
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Provide data on patient characteristics10 years
The primary objective of this study is to generate a national, multi-center registry of patients using lower-limb prosthesis, their profiles and devices, and their long-term follow-up and clinical outcomes.